Lyumjev ® (insulin lispro – aabc) injection

100 units/mL, 200 units/mL

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Is Lyumjev® (insulin lispro-aabc) approved to be used in a pump?

Since August 13, 2021, Lyumjev 100 units/mL is approved for use in an insulin pump.

US_cFAQ_URI012_PUMP_APPROVAL
US_cFAQ_URI012_PUMP_APPROVAL
en-US

Lyumjev Approval for Use in an Insulin Pump

Since August 13, 2021, Lyumjev 100 units/mL has been approved to be used in insulin pumps in the United States.1

Lyumjev 100 units/mL should be administered in accordance with the instructions provided by the pump manufacturer. Refer to the continuous subcutaneous insulin infusion pump user manual to see if Lyumjev can be used with the insulin pump.1 

Do not administer Lyumjev 200 units/mL using an insulin pump.1

Reference

1Lyumjev [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.

Date of Last Review: August 13, 2021


Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 7pm EST

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical